← Back to Search

Behavioral Intervention

Advance Care Planning for Alzheimer's and Dementia (AD-ACP Trial)

N/A
Waitlist Available
Led By Christine E. Kistler, MD, MASc
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PLwD will be eligible only after confirmation of the presence of the AD/ADRD diagnosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 months
Awards & highlights

Summary

This trial will test a toolkit called Dementia Advance Care Planning (AD ACP) to see if it helps people with dementia and their primary care team members have better discussions about their care preferences. The

Who is the study for?
This trial is for people living with Alzheimer's Disease or a related dementia. Participants should be involved in primary care and willing to discuss their care preferences over an 18-month period. Specific eligibility criteria are not provided, but typically include factors like age, disease stage, and cognitive ability.
What is being tested?
The study compares usual care with a new approach where the primary care team receives training to better plan advanced care for patients with dementia. The goal is to see if this training improves discussions about future medical decisions between patients and caregivers.
What are the potential side effects?
Since this trial involves communication strategies rather than medications, traditional side effects are not expected. However, participants may experience emotional or psychological discomfort when discussing sensitive topics about future health decline and end-of-life preferences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My Alzheimer's or dementia diagnosis has been confirmed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Goals of Care Discussions
Secondary study objectives
Acceptability
Adoption
Appropriateness
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: Advance Care Planning TrainingExperimental Treatment1 Intervention
1. Dementia-specific education: Stage-specific findings and challenges, including AD/ADRD staging, capacity assessment, symptom burden, hospice guidelines, etc - 10-minute didactics, delivered via video conferencing and via the website 2. ACP communication skills: Context-specific skills and tips on how to slow down, set the communication stage, active listening, respect for personhood and cultural norms, and common, useful language to prepare patients and families- 10-minute didactics, delivered via video conferencing and via the website 3. Clinical implementation support: Coding and billing information for ACP and ACP templates, an action plan for each team member participant, monthly ACP audit-and-feedback to participants, monthly coaching sessions, site champion, refresher sessions, and educational in-services as needed - Resources at the end of the training session, available on the website, monthly feedback reports on ACP practices, periodic coaching
Group II: Care as Usual: No TrainingActive Control1 Intervention
These primary care teams will not receive the Advance Care Planning training. Clinics randomized to the control arm will have access to voluntary, routine ACP training sessions provided by UNC HEALTH. We will provide the control clinics summary reports of their ACP practice outcomes at the end of the 18-month follow-up period, which can be used in future practice improvement efforts.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,883 Total Patients Enrolled
166 Trials studying Aging
80,102 Patients Enrolled for Aging
University of North Carolina, Chapel HillOTHER
1,543 Previous Clinical Trials
4,248,922 Total Patients Enrolled
6 Trials studying Aging
6,014 Patients Enrolled for Aging
University of PittsburghLead Sponsor
1,762 Previous Clinical Trials
16,347,883 Total Patients Enrolled
8 Trials studying Aging
1,922 Patients Enrolled for Aging
~80 spots leftby May 2027